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ABSTRAK  
Demam kepialu merupakan penyakit bawaan makanan yang disebabkan oleh 
jangkitan bakteria Salmonella enterica serovar Typhi (S. Typhi). Demam kepialu 
masih lagi menjadi satu permasalahan kesihatan awam di kebanyakan negara mundur 
dan negara yang sedang membangun termasuk Malaysia. Dianggarkan kira-kira 22 
juta kes dan 216,000 kematian akibat daripada jangkitan S. Typhi telah dilaporkan di 
seluruh dunia setiap tahun. Membran protin luar (OMP) spesifik dengan berat 
molekul pada 50 ribu Dalton (50 kDa), daripada S. Typhi telah dilaporkan 
berkemungkinan memainkan peranan dalam jangkitan demam kepialu. Oleh sebab itu 
OMP 50 kDa daripada S. Typhi telah digunakan sebagai molekul sasaran dalam 
mengesan S. Typhi. Terkini, antibodi monoklonal dan poliklonal telah banyak 
digunakan untuk pembangunan kit diagnostik bagi mengesan antigen daripada 
organisma penyebab penyakit. Namun demikian disebabkan ketidaktahanan antibodi 
tersebut ke atas suhu yang tinggi atau keperluan mengekalkan rantaian suhu telah 
menyebabkan kesukaran kit diagnostik tersebut digunakan dilapangan. Sebagai 
pendekatan baharu, aptamer RNA telah dipilih untuk mengesan antigen daripada 
bakteria S. Typhi untuk mendiagnosis demam kepialu.. Berbanding antibodi, beberapa 
ciri aptamer seperti ketahanan kepada suhu yang tinggi menyebabkan ia lebih bagus 
untuk digunakan dalam teknologi diagnostic dimana ia boleh mengantikan antibodi 
pada masa akan datang. Aptamer merupakan satu jalinan asid nukleik sintetik yang 
membentuk struktur dimensi yang unik, membolehkan ia berinteraksi khusus kepada 
molekul sasaran. Aptamer dihasilkan melalui teknik evolusi ligan bersistematik 
dengan cara penkayaan eksponen (SELEX). Satu proses menyaring ligan tertentu dari 
kumpulan besar “oligonucleotides” melalui ulangan proses pemilihan dan 
penggandaan, Melalui kajian ini, SELEX telah berjaya mengasingkan enam calon 
xiv 
 
aptamer. Analisis jujukan menunjukkan urutan konsensus GUU, GUUU, dan 
GUUUU muncul di kebanyakan calon-calon aptamer yang berpotensi menjadi tapak 
lekatan pada molekul sasaran. Aktiviti pelekatan antara aptamer dan protin sasaran 
telah dinilai melalui ujian peralihan pergerakan secara elektroforetik (EMSA). 
Daripada enam calon aptamer yang diperolehi hanya aptamer ST01, ST03 dan ST04 
berinteraksi khusus dengan protin OMP 50 kDa S. Typhi. Oleh kerana protin OMP 50 
kDa merupakan satu gabungan protin komplek yang terdiri daripada 3 subunit, 
subunit 1 protin flagellin, subunit 2 “glycerol kinase” dan subunit 3 protin TolC, maka 
tiga aptamer terpilih telah diuji seterusnya ke atas subunit-subunit tersebut secara 
berasingan. Keputusan menunjukkan bahawa aptamer ST01 dan ST03 dapat 
berinteraksi khusus kepada kedua-dua subunit 2 dan 3, manakala ST04 tidak 
berinteraksi pada mana-mana subunit. Kesimpulannya, ST04 hanya melekat kepada 
gabungan komplek protin OMP 50 kDa dan aptamer ST01 dan ST03 boleh mengikat 
kepada gabungan komplek protin OMP 50 kDa dan dua subunitnya secara berasingan. 
Tiga aptamer ini ST01, ST03 ST04 mempunyai potensi untuk digunakan sebagai 
ligan pelekatan yang kuat untuk menangkap dan seterusnya mengesan S. Typhi dalam 
usaha untuk mengesan agen penyebab demam kepialu.   
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ABSTRACT  
Typhoid fever is a food borne illness caused by the bacteria, Salmonella enterica 
serovar Typhi (S. Typhi). Typhoid fever remains a public health problem in many of 
the underdeveloped and developing countries including Malaysia. It has been 
estimated around 22 million cases and 216,000 related deaths occurred worldwide 
annually. The 50 kDa outer membrane protein (OMP) of S. Typhi has been 
considered as a possible candidate that plays role during the infection of typhoid. 
Therefore 50kDa OMP of S. Typhi was used as target molecule in detecting of S. 
Typhi. Currently, monoclonal and polyclonal antibodies were widely used in 
diagnostic kit development for antigen detection from the organisms that caused the 
disease. However, this diagnostic kits are not suitable to be used in the fields because 
of the antibody are not stable at high temperature and need to maintain the 
temperature chain. Thus, as a new approach, RNA aptamers were selected for S. 
Typhi antigen detection in the diagnosis of typhoid fever. Compare to antibody, a few 
properties of aptamer such as more stable at high temperature make this aptamer more 
suitable to be used in diagnostic technology, where it can substitute the antibody in 
the future.  Aptamer is a synthetic, single stranded nucleic acid that folds up into a 
unique two or three-dimensional structure, allowing them to bind specifically to the 
target molecules. The aptamer was generated using Systematic Evolution of Ligands 
by Exponential Enrichment (SELEX) technique. SELEX is a process for screening 
specific ligands from large libraries of oligonucleotides by an iterative process of 
selection and amplification. SELEX demonstrated six potential aptamer candidates 
that dominated the final pool of oligonucleotides. The alignment analysis showed the 
consensus sequences GUU, GUUU, and GUUUU occurred in most of the aptamer 
candidates which could be the potential binding site of the aptamers towards target 
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molecule. The binding activity between the aptamers and the target protein was 
evaluated by electrophoretic mobility shift assays (EMSA). From the six aptamer 
candidates isolated, only aptamer ST01, ST03 and ST04 showed binding affinity 
towards 50 kDa OMP of the S. Typhi. Since 50 kDa OMP of S. Typhi is in a complex 
formation, comprising  3 subunits, subunit 1, marker flagellin protein, subunit 2, 
glycerol kinase and subunit 3 TolC protein, the three selected aptamers were further 
tested against the subunits individually. The results showed that aptamers ST01 and 
ST03 bound to both subunits 2 and 3, while ST04 could not bind to any subunits. As a 
conclusion, aptamers ST01 and ST03 can bind to the 50 kDa OMP complex and its 
subunits individually and ST04 would only bind to the 50 kDa OMP complex. These 
three aptamers, ST01, ST03 and ST04 have the potential to be used as high affinity 
ligands for the capture and subsequently detection of S. Typhi in the diagnosis of 
typhoid fever.  
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CHAPTER ONE:  
INTRODUCTION  
 
1.1 Introduction to typhoid fever and Salmonella enterica serovar Typhi  
1.1.1. Introduction of typhoid fever 
Typhoid fever is a food borne illness, which is an acute systemic infection disease. 
The disease is transmitted through the ingestion of the food or drink contaminated by 
the feces and urine infected with bacteria Salmonella enteric serovar Typhi (S. Typhi) 
(Fischer et al., 2007, Ismail et al., 1991). Thus, the typhoid fever usually occurs in 
countries or places that lack clean water and basic hygienic practices (Fischer et al., 
2007). Children especially in endemic areas, travelers and microbiological laboratory 
technicians are particularly at risk of exposed to the disease (Hamid and Jain, 2008). 
This febrile illness can also be transmitted in crowded and impoverished populations 
with inadequate sanitation that led to unsafe water and food for consumption.  
 
Typhoid fever is a global health problem. Variable estimates of typhoid fever have 
been published in the scientific literature (Crump and Mintz, 2010). The true 
incidence of typhoid fever is not known. A study published in 2004 estimated 22 
million cases and 216,000 related deaths occurring worldwide each year particularly 
among children and adolescent (Newton and Mintz, 2014, WHO, 2013). It has been 
shown that the incidence of typhoid was high especially in south central and southeast 
Asia, also southern Africa with more than 100 cases per 100,000 population per year 
(Ismail et. al., 2009). However, for the rest of Asia, Africa and Latin America the 
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incidence was moderate with 10 – 100 cases per 100,000 populations (Figure 1.1) 
(Crump et al., 2004, Crump and Mintz, 2010). 
 
 
 
Figure 1.1 : Worldwide distribution of typhoid fever.  
Source : Crump et al. (2004) 
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In Malaysia, typhoid fever is endemic and periodically gives rise to outbreak (Anita et 
al., 2012). According to the reports from Ministry of Health from 2004 – 2012 there 
were between 200 – 1,072 cases (Table 1.1) and incidence rate was less than 5 per 
100,000 population for over the country (Table 1.2) (MOH, 2011, Malik and Malik, 
2001). . The last big outbreak was reported in 2005 in state of Kelantan involving 887 
cases (Table 1.1) with incidence rate of 58.9 per 100,000 population (Table 1.2), but 
for overall in Malaysia, the incidence rate on that year was 4.1 per 100,000 population 
(Table 1.2) which is still not considered as highly endemic (MOH, 2011, Department 
of Statistic Malaysia, 2014).  
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Table 1.1 Typhoid incidence case for each state in Malaysia (2004-2013) which 
showed that Kelantan has a higher incidence compared to other states 
State 
Year 
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
Malaysia 484 1,072 204 325 201 303 210 242 218 218 
Johor 14 12 13 44 8 14 13 7 NA NA 
Kedah 21 12 8 9 5 18 2 8 NA NA 
Kelantan 111 887 76 136 72 85 46 84 31 NA 
Melaka 2 1 2 7 1 3 NA NA NA NA 
N.Sembilan 4 7 NA 1 2 5 2 1 NA NA 
Pahang 9 12 2 17 7 5 3 31 NA NA 
Penang 5 9 3 16 3 NA 2 1 NA NA 
Perak 24 18 13 21 9 11 5 8 NA NA 
Perlis 3 NA 1 NA 1 NA 2 NA NA NA 
Selangor 50 26 17 22 22 88 31 38 NA NA 
Terengganu 32 8 9 3 2 6 4 NA NA NA 
Kuala Lumpur 12 2 2 7 6 7 12 7 NA NA 
Sabah 163 62 41 36 59 54 82 185 NA NA 
Sarawak 34 16 17 6 4 7 6 50 NA NA 
NA = Not available 
Source: Department of Statistic Malaysia, (2014) 
 
Table 1.2 Typhoid incidence rate for each state in Malaysia (2004-2013) which 
showed that Kelantan has a higher incidence compared to other states 
State 
Year 
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
Malaysia 1.9 4.1 0.8 1.2 0.7 1.1 0.7 0.8 0.7 0.7 
Johor 0.5 0.4 0.4 1.4 0.2 0.4 0.4 0.2 0.2 0.4 
Kedah 1.2 0.7 0.4 0.5 0.3 0.9 0.1 0.4 0.2 0.3 
Kelantan 7.5 58.9 5.0 8.7 4.5 5.2 3 5.2 1.9 2.5 
Melaka 0.3 0.1 0.3 1.0 0.1 0.4 NA NA NA 0 
N. Sembilan 0.4 0.7 NA 0.1 0.2 0.5 0.2 0.1 0.2 0.6 
Pahang 0.6 0.8 0.1 1.2 0.5 0.3 0.2 2.0 0.4 03 
Perak 1.1 0.8 0.6 0.9 0.4 0.5 0.2 0.3 0.7 0.2 
Perlis 1.4 NA 0.4 NA 0.4 NA 0.9 NA NA 1.2 
Penang 0.4 0.6 0.2 1.1 0.2 NA 0.1 0.0 0.1 0.6 
Sabah 5.5 2.1 1.3 1.1 1.8 1.6 2.5 1.5 1.1 1.6 
Sarawak 1.5 0.7 0.7 0.3 0.2 0.3 0.2 0.3 1.4 0.6 
Selangor 1.1 0.6 0.4 0.4 0.4 1.7 0.6 0.7 0.6 0.8 
Terengganu 3.2 0.8 0.9 0.3 0.2 0.5 0.4 NA 0.3 0.2 
Kuala Lumpur 0.8 0.1 0.1 0.4 0.4 0.4 0.7 0.4 2.0 0.4 
NA = not available 
Source: Department of Statistic Malaysia (2014)  
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1.1.2. Introduction to Salmonella enterica serovar Typhi 
Salmonella is a member of family Enterobacteriaceae. The genus Salmonella is divided 
into two species: Salmonella enterica and Salmonella bongori. S. enterica was then 
divided into six distinct subspecies according to biochemical differences, which are 
Salmonella enterica subsp. enterica (subsp. I), Salmonella enterica  subsp. salamae 
(subsp. II), Salmonella enterica  subsp. arizonae (subsp. IIIa), Salmonella enterica subsp. 
diarizonae (subsp. IIIb), Salmonella enterica subsp. houtenae (subsp. IV) and Salmonella 
enterica subsp. indica (subsp. VI). Meanwhile S. bongori was originally identified as 
subsp. V, but now was recognized as separated species from S. enterica (McQuiston et. 
al., 2008).  
 
In addition, the salmonellae are further subdivided by using a subtyping method based on 
two surface structures, the somatic O antigen of lipopolysaccharide and the flagellar H 
antigen. There are 2 463 serotypes (serovars) of Salmonella. The majority of the 
Salmonella serotypes belong to Salmonella enterica subsp. enterica with 59% from all 
serotypes as inTable 1.3.  Salmonella Typhi is one of the example of serotypes under 
Salmonella enterica subp. enterica. For named serotypes, the serotype name is not 
italicized and the first letter is capitalized. Salmonella serotype Typhi would be 
referred as Salmonella enterica subsp. enterica serotype Typhi. At the first citation of 
a serotype the genus name is given followed by the word “serotype” (serovar) or the 
abbreviation “ser.” and then the serotype name, for example,Salmonella serotype or 
ser. Typhi. Subsequently, the name may be written with the genus followed directly 
by the serotype name for example, Salmonella Typhi or S. Typhi (Brenner et. al., 
2000).   
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Table 1.3 : Number of serotypes within subspecies of Salmonella (Brenner et. al., 2000) 
Salmonella species and subspecies  No. of serotypes within subspecies 
S. enterica subsp. enterica (I) 1 454  
S. enterica subsp. salamae (II) 489 
S. enterica subsp. arizonae (IIIa) 94 
S. enterica subsp. diarizonae (IIIb) 324 
S. enterica subsp. houtenae (IV) 70 
S. enterica subsp. indica (VI) 12 
S. bongori (V) 20 
Total  2 463 
.  
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S. Typhi is an important pathogen exclusively for humans that causes typhoid or 
enteric fever (Pan et al., 2005). It is a gram-negative bacteria, rod-shaped, 
noncapsulated, nonsporulating, facultative anaerobic bacilli, with characteristic 
flagellars, somatic and outer coated antigens (Hamid and Jain, 2008). It is motile by 
means of peritrichous flagella (H-d antigen) which is also came across in 80 other 
bioserotypes of Salmonella (Ismail, 2009). It is also serogically positive for 
lipopolysaccharides antigens O9 and O12 (somatic antigen), protein flagellar (H-d 
antigen) and capsular polysaccharide (Vi antigen) (Ismail, 2009). The Vi antigen is 
both virulence factor and protective antigen of S. Typhi. The presence of the Vi 
antigen on the isolated samples can be detect by using antiserum agar method (Nolan 
et al., 1980) 
 
S. Typhi is distinguished from other salmonellae species by its metabolic 
characteristics such as lactose or sucrose fermentation, production of hydrogen sulfide 
(H2S) which is usually observed as a crescent-shaped wedge of black precipitate 
forming at the interface of the slant and butt in triple sugar iron media (Ismail, 2009). 
Its capsular polysaccharide (Vi antigen) is a virulence factor and can act as protective 
antigen.. In addition, inability of S. Typhi to cause to similar disease in other animal 
species showed that it is a human adapted pathogen (Crump and Mintz, 2010) and 
ability to establish a chronic infection in the host gall bladder. According to World 
Health Organization (WHO), (2013) about 3 – 5% of individuals develop chronic 
carrier phases after a year of an acute infection (Ismail, 2009, Crawford et al., 2008). 
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1.1.3. Diagnosis of Typhoid fever 
The isolation of S. Typhi from feces, urine, bone marrow and blood via bacteria 
culture method remained as the gold standard for the diagnosis of the typhoid. The 
other methods available include the Widal test (Ismail et al., 1991), dot Enzyme 
immunoassay (EIA) (Choo et al., 1994) and molecular approaches such as 
Polymerase Chain Reaction (PCR) (Joshi et al., 2009). However, all of these methods 
have several limitations that will be discussed later. Until 1991, Ismail et. al., 1991, 
had shown that the 50 kDa specific outer membrane protein (OMP) of S. Typhi is a 
specific antigenic protein to S Typhi and has been used for the development of 
typhoid detection kit called TyphiDot 
TH
 (Ismail et al., 1991).  
 
TyphiDot
TH
 is a dot enzyme immunosorbent assay kit, which has been developed for 
the detection of specific IgM and IgG antibodies to the 50 kDa protein in typhoid 
patients. The assay was developed to cater for the need of a rapid, simple and 
inexpensive test for diagnosis of acute typhoid fever, as compared to the gold standard 
culture method and the Widal test which is difficult to interpret. The techniques using 
the outer membrane protein was found to be sensitive and specific and could produce 
results within 3 hours compared to 3 to 7 days via the conventional culture method. 
(Choo et al., 1994, Choo et al., 1997).  
 
When developing a diagnostic test, a diagnostic kit must be rapid, specific and 
sensitive. The traditional culture based assay is still considered as the gold standard 
method for diagnosis the typhoid fever, simply for the lack of a better alternative 
method. Unfortunately, the culture based method requires five to seven days to 
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produce final results and the technique is laborious (Joshi et al., 2009). Therefore, 
there is an urgent need for a diagnostic method for typhoid that is rapid and accurate. 
For effective management, a rapid diagnosis results is needed to provide the 
information for initial clinical decision making (Ismail et al., 1991).  
 
Alternatively, immunological and molecular assays have been developed and may 
even be more sensitive compared to the culture method. Immunological assay 
involves the antibody or antigen based detection. However, sometimes, this assay 
could produce negative results to detect for antibody response in immune-
compromised patients. This is due to the light chain and heavy chain of the antibody 
that could produce cross reactive results (Yoshida et al., 2008). Even molecular 
technique such as PCR could shorten the time, it is still cannot reduce the time for 
enrichment steps to increase the concentration of targets. In addition, the residual 
matrix-associated inhibitors also need to be removed because they oftentimes 
compromised molecular detection which will have an impact on the sensitivity and 
specificity of the assays (Joshi et al., 2009). Thus, a rapid as well as sensitive and 
specific method is still needed for detection of S. Typhi.  
 
Nevertheless, the detection of S. Typhi in complex sample matrices such as feces, 
foods and environmental samples are challenging for a number of reasons. First, time 
consuming culture-based enrichment steps are usually necessary to increase the target 
count numbers prior to the application of detection methods. Second, although 
molecular technique, such as PCR can shorten the detection time, this technique has 
not allowed for the elimination of enrichment step, largely because high levels of 
target is still necessary. This is due to the small amplification volumes (1-10 µl) in 
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contrast to much larger sample volumes (1 – 25 mg or more g or ml) (Joshi et al., 
2009).  
 
Although new rapid test methods appear frequently, these almost always focused on 
the detection aspects and neglect the need for pre analytical sample processing prior 
to detection. The fact remains that detection of pathogens in these complex matrices 
would be more sensitive if the agent was concentrated and purified from the matrix 
prior to detection. 
 
1.1.4. The 50 kDa outer membrane protein (OMP) of S. Typhi  
The OMP of S. Typhi has been considered as a possible candidate for conferring 
protection against typhoid (Hamid and Jain, 2008). Due to its location on the surface 
of the bacteria, OMPs have been considered as valuable immunogens (Ismail et al., 
1991). Over the past years, several Salmonella OMPs have been investigated as 
potential vaccine candidates, virulence factors and diagnostic antigens. The molecular 
structure and function of OMPs and their respective genes also have been studied 
(Hamid and Jain, 2008). In the previous study the 50 kDa OMP from S. Typhi was 
revealed as a specific as well as antigenic protein for S. Typhi (Ismail et al., 1991). the 
50 kDa OMP is a protein by nature and not a Vi (capsular), dH (flagellar) or O9 
(somatic) antigen of S. Typhi (Ismail et al., 1991). The gene that encodes the 50 kDa 
OMP of S. Typhi was submitted to Genbank as ST050 gene (1476 bp) with accession 
number BD079162 (Ismail et al., 2009).and was patented under Universiti Sains 
Malaysia with US pattern number 20, 020, 012, 668 (Ismail et al., 2009). 
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In addition, the protein was also used in the development of detection kit for typhoid 
fever, Typhidot
TH
. However the kit was designed to detect the antibodies produced in 
the patient during infection (Gopalakrishnan et al., 2002) instead of directly detecting 
the organism itself. Thus, in this study, we attempted to produce candidates in the 
form of RNA aptamers that can bind specifically to 50 kDa OMP of  S. Typhi and to 
be use in the development of diagnostic assays. In addition, it also can be applied in 
detection of S. Typhi in food or environmental samples.  
 
1.2. Introduction to aptamers 
1.2.1. Theory and history of aptamers  
Nucleic acids were considered as template or linear carriers of information. 
Meanwhile, protein molecules carried out most of the cell function, which possess 
complex three dimensional structures. With the discovery of the catalytic activity of 
RNAs by Guerrier and Altman, (1984), they found that nucleic acids were possessed a 
selectable both genotype and phenotype (Guerrier and Altman 1984, Wang 2008).. 
The formation of specific complexes with protein also has been known since the 
1960s. However, it was not shown that the formation of ribonucleoprotein complexes 
can be used as a directly selectable phenotype (Burke and Berzal-Herranz, 1993). 
 
This discovery supports the “RNA World” theory by Gilbert, (1986), where RNA 
carried out most of the biochemical functions in the cell (Gilbert, 1986, Klaussman, 
2006). Because of the ability of RNA to catalyse all biological reactions similar to 
enzymes, such RNA are called ribozymes (Pyle, 1993, Wang, 2008). For example the 
ribozymes with RNA polymerase activity replicated all the functional RNA structure 
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in the cell. Thus, the probability of finding RNA in a pool of random molecules with 
any binding or catalytic activity could be like to the polymerase function (Klussmann, 
2006).  
 
The aptamers were discovered in early 1990s by Ellington and Szostak (Ellington and 
Szostak, 1990, Klussmann, 2006). A group of Joyce, Gold and Szostak had carried 
out a preliminary work of in vitro selection of RNA to identify unique RNA structures 
that displayed functions such as binding specifically to target molecules and also the 
enzymatic activity of the reaction (Klussmann, 2006). Ellington and Szostak 
demonstrated that large libraries of RNAs could be screened in vitro for RNA ligands 
that bind to a variety of organic dye and they named these RNAs as aptamers 
(Ellington and Szostak, 1990). The term aptamer was derived from the Latin word 
“aptus”, which means to fit and to emphasize the “lock and key” relationship between 
aptamers and the target molecules (Becker and Becker, 2006) and the Greek word 
“meros” which means particles (Ellington and Szostak, 1990, Wang, 2008). In 
addition to Ellington and Szostak’s discovery, Tuerk and Gold discovered the RNA 
ligand that bind to Bacteriophage T4 DNA Polymerase (Tuerk and Gold, 1990, Wang, 
2008). Tuerk and Gold termed the in vitro selection process of the functional RNA as 
“SELEX” which stand for Systemic Evolution of Ligands by EXponential enrichment 
(Tuerk and Gold, 1990, Klussmann, 2006).  
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1.2.2. Aptamer properties 
Aptamers are synthetic, single stranded nucleic acids of either DNA or RNA that can 
fold into different two or three dimensional structures and bind to target molecules 
with high affinity and specificity (Tuerk and Gold, 1990, Joshi et. al., 2009,  Ye et. 
al., 2012). With the specific and complex three dimensional structure characteristic 
such as stems, loops, hairpin, pseudoknots, bulges, triplexes, and/or quadruplexes, 
they can bind to a wide variety of targets (Wang, 2008). These distinct three 
dimensional structures, allow them to form stable and specific complexes with wide 
target of complementary shape (Ye et. al., 2012). The binding of the aptamers to the 
target molecules are based on structure compatibility such as aromatic rings, 
electrostatic and van der Waals interactions, hydrogen binding or a combination of 
these effects (Wang, 2008). These interactions form stable complexes, since the 
aptamers exhibit high affinity binding to their targets with kinetic dissociation 
constants (Kd) value in the low nanomolar (nM) to picomolar (pM) range (Jin and 
Bowser, 2011, Polisky, 1998). Hence, aptamers could bind with high affinity 
(Tombelli et al., 2005) and can be specific against a wide variety of targets (Joshi et. 
al., 2009) ranging from small molecules such as metal ions, organic dye, amino acids 
or short peptides (Table 1.4), to large proteins including cell membrane proteins 
(Table 1.4) (Proske et. al., 2005, Tombelli et. al., 2005) or complex target such as 
whole cells, viruses, virus-infected cells or bacteria (Table 1.5).  
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Table 1.4 : The target molecules that have been used for aptamers selection through 
SELEX process (Hamula et. al., 2011a) 
Pathogen/cell Target molecules Reference  
HIV-1 Integrase  Allen et. al., 1996 
 Reverse transcriptase  Tuerk and Gold, 1990 
 Nucleocapsid protein  Kim et. al., 2002 
 Tat protein  Yamamoto et. al, 2000 
 R5 SV glycoprotein  Khati et. al., 2003 
 Drug-resistant reverse 
transcriptase  
Li et. al., 2008 
   
Hepatitis C virus RdRp  Jones et. al., 2006 
 NS3 Kumar et. al., 1997 
 NS3 helicase  Hwang et. al. 2004 
 30’X tail  Fukuda et. al., 2008 
 NS3 protease  Fukuda et. al., 2000 
 NS5B RNA polymerase  Biroccio et. al., 2002 
 IRES (internal ribosome entry 
site)  
Fukuda et. al., 2008 
   
Hepatitis B virus HBsAg surface antigen  Liu et. al.,  2010 
   
Influenza virus H5N1 HA protein  Cheng et. al., 2008 
   
SARS coronavirus NTPase, Helicase  Jang et. al., 2008 
   
Apple stem pitting virus Coat proteins  Lautner et. al., 2010 
   
Foot and mouth disease 
virus 
VP1 protein  Bruno et. al., 2008a 
   
Prion proteins PrPsc  Proske et. al., 2002 
 PrPsc fibrils  Rhie et. al., 2003 
 rPrPsc  Weiss et. al., 1997 
 rPrPc  Takemura et. al., 2006 
 Mammalian prion proteins  Bibby et. al., 20008 
   
Escherichia coli Release factor 1  Sando et. al., 2007 
 Core RNA Polymerase  Kulbachinskiy et. al., 
2004 
 Lipopolysaccharide O111: B4  Bruno et. al., 2008b 
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Table 1.4 (Continued)  
Pathogen/cell Target molecules Reference 
Mycobacterium M. avium sub. 
paratuberculosis MAP0105c 
gene product  
Bannantine et. al., 2007 
 M. tuberculosis MPT64 
protein  
Qin et. al., 2009 
 M. tuberculosis 
polyphosphate kinase 2  
Shum et. al., 20011 
   
Francisella tularensis Protein lysate  Vivekananda and Kiel, 
2006 
   
Campylobacter jejuni Surface extract  Bruno et. al., 2009 
 Protein lysate  McMasters and Stratis-
Cullum, 2006 
   
Salmonella enteric serovar Typhi Type IVB pilus  Pan et. al., 2005 
 Typhimurium outer 
membrane proteins 
Joshi et. al., 2009 
   
Listeria monocytogenes Internalin A  Ohk et. al., 2010 
   
Leishmania infantum H2 Antigen  Ramos et. al.,2003 
   
Burkholderia 
pseudomallei 
BipD/BopE/BPSL2748  Gnanam et. al.,2008 
   
Ustilago maydis (corn 
pathogen) 
RNA-binding protein Rrm4  Konig et. al., 2007 
   
Venezuelan equine 
encephalitis virus 
Capsid protein  Kang et. al., 2007 
   
Bacterial toxins Staphylococcal enterotoxin B,  Bruno and Kiel 2002 
 Cholera toxin Bruno and Kiel 2002 
 Botulinum neurotoxin  Tok and Fischer, 2008 
 Shiga toxin Fan et. al., 2008 
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Table 1.5 Whole bacterial cells and viral particles used in selection of aptamers by 
SELEX (Hamula et. al., 2011a, Hamula et. al., 2006) 
Target 
molecule 
Pathogen Reference 
Viral particles  Rous Sarcoma Virus particles Pan et. al., 1995 
 Bacillus anthracis spores  Fan e. al., 2008 
 Live African Trypanosomes  Homann et. al., 2006 
 Trypanosoma cruzi  Ulrich et. al., 2002 
 Bacillus thurigensis spores  Ikanovic et. al., 2007 
 Human Influenza A virus particles Gopinanth et. al., 2006 
 Vaccinia virus particles  Nitsche et. al, 2007 
   
Whole bacterial 
cell 
Mycobacterium tuberculosis  Chen et. al., 2007 
 Lactobacillus acidophilus  Hamula et. al., 2008 
 Escherichia coli DH5α So et. al., 2008 
 MS-2 Bacteriophage particles  Fan et. al., 2008 
 Mammalian cells expressing Hepatitis C 
E2 envelope glycoprotein  
Chen et. al, 2009 
 Vaccinia-infected mammalian cells  Tang  et. al. , 2009 
 Staphylococcus aureus  Cao et. al., 2009 
 Streptococcus pyogenes  Hamula et. a., 2011b 
 Pseudomonas aeruginosa  Wang et. al., 2011 
 Campylobacter jejuni  Dwivedi et. al., 2010 
   
Whole cell Human red blood-cell ghosts  Morris et. al., 1998 
 Heat-killed anthrax spores Bruno and Kiel, 1999 
 Trypsanoma cruzi Ulrich et. al., 2004 
 Transformed YPEN-1 endothelial cells  Blank et. al., 2001 
 Glioblastoma-derived U251 cells  Daniels et. al., 2003 
 Differentiated P12 cells  Wang et. al., 2003 
 Receptor tyrosine kinase-expressing 
P12 cells  
Cerchia et. al., 2005 
 Human osteoblasts  Guo et. al., 2005 
 Francisella tularensis antigens Vivekananda and Kiel, 
2006 
 Recombinant growth factor-βType III 
receptor-expressing Chinese hamster 
ovary (CHO) cells 
Ohuchi et. al., 2006 
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The exceptional specificity displayed by aptamers can even discriminate between 
closely related molecules or different conformational states of the same target 
molecules (Conrad and D.Ellington, 1996). As an example Zueva et. al., 2011 
developed aptamers for the specific recognition of highly metastatic cells. Two 
malignant isogenic hamster cell lines, HET-SR-1 (HM) and HET-SR (LM) were used 
as samples. These two cells were similar in many aspects, including tumorigenicity 
and growth properties, but the former shows greater metastatic potential in vivo 
compared to the latter. Aptamer E10 and E37 were successfully identified as 
specifically bound to the highly metastatic cell line HM and not to LM (Zueva et. al., 
2011). The other example is from Cerchia et. al., 2009, where, they generated 
aptamers specifically for malignant human glioma cell line U87MG. The aptamer can 
discriminate between target cells with the highly related phenotype but poorly 
tumorgenic human glioma cell line, T98G within the same tumor (Cerchia et. al., 
2009). 
 
1.2.2.1. Aptamer versus antibody 
Until recently, monoclonal and polyclonal antibodies were the most commonly used 
to capture ligands or antigen from pathogen in a wide range of medical, biology and 
diagnostic applications. However, there are certain limitations associated with 
antibodies. Several properties of aptamers make them more attractive diagnostic agent 
and in some cases even surpass antibodies (Table 1.6). Thus it could be the rival for 
the antibodies for the future. 
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Table 1.6 : Properties of aptamers and  antibodies (Jayasena, 1999, Nimjee et al., 2006) 
 Antibodies  Aptamers  
Selection procedure requires a biological system, therefore difficult to raise 
antibodies to toxins (not tolerated by animal) or non-
immunogenic targets 
chemical process carried out in vitro, therefore can 
target any molecules 
Working condition Limited to physiologic conditions for optimizing 
antibodies for diagnostics 
Can select for ligands under a variety of conditions for 
in vitro diagnostics 
Time and expense Screening monoclonal antibodies time consuming and 
expensive 
Iterative rounds against known target limits screening 
processes 
activity Activity of antibodies vary from batch to batch Uniform activity regardless of batch synthesis 
Target site Immune system determines target site of protein Investigator determines target site of protein 
modification Limited modifications of molecule Wide variety of chemical modifications to molecule for 
diverse functions 
immunogenicity Significant No evidence  
Cross-reactive 
compound 
No method for isolating cross-reactive compound Cross-reactive compounds can be isolated utilizing 
toggle strategy to facilitate preclinical studies 
Reverse activity No rational method to reverse molecules Aptamer-specific antidote can be developed to reverse 
the inhibitory activity of the drug 
Kinetic parameters Kinetic parameters of Ab-Ag interactions are difficult 
to be changed on demand 
Kinetic parameters such as on/off rates can be 
changed on demand 
Shelf-life and 
temperature 
stability 
limited shelf life and sensitive to temperature and 
may undergo denaturation  
unlimited shelf life and denatured aptamers can be 
regenerated, stable to long term storage and can be 
transported at ambient temperature 
labelling Labeling of antibodies can cause loss in affinity Reporter molecules can be attached to aptamers at 
precise locations not involved in binding 
Size Large, MW : 150 kDa Small, MW : 8 – 12 kDa 
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The preparation and selection process of aptamers are carried out in vitro via chemical 
process compared to antibody production which required a biological system such as 
mouse. These processes need the iterative rounds against the target, which is faster and 
cheaper compared to the production of antibodies. The production of antibody is 
laborious and could become very expensive especially when searching for rare antibodies 
that require screening of large number of colonies (Jayasena, 1999, Wang 2008). The 
performances of the same antibody could vary from batch to batch requiring 
immunoassays to be reoptimize with each new batch of antibodies. But for the aptamer, 
the activity is uniform for every batch of synthesized (Jayasena, 1999). The size of the 
aptamer is also small ranging from 25 – 100 nucleotides long with molecular weigh 8 to 
12 kDa. This small size enables them to travel in circulation faster, penetrate tissue better 
and distribute in organs more efficient (Wang, 2008).  
 
Aptamer acts similarly as antibodies by folding into two or three dimensional structures 
and binding to the target molecules. Aptamers bind to their targets with affinities 
comparable to the monoclonal antibodies with a Kd is in low nM to pM, and even 
sometimes higher than antibodies (Nimjee et. al., 2006). For example, in a study where 
aptamer had been used against the IgG substitute the secondary antibody, the Kd showed 
lower than 15pM to the IgG (Yoshida et. al., 2008). In addition, the binding specificity of 
aptamers is also very high and they could distinguish between related protein or cells that 
share common sets of structural domain (Wang, 2008).  
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Therefore, aptamers could target a wide range of target under a variety of condition for in 
vivo diagnostic. In comparison it would be difficult to raise antibodies to toxins or non-
immunogenic targets and limited to physiologic condition (Nimjee et. al., 2006). The 
pharmacokinetic parameters of binding reaction could be changed according to the 
demand of the reaction, but it is difficult to modify antibody reactions. On the other hand, 
the chemical process in the making of aptamers could be modified for diverse functions 
(Jayasena, 1999). Commonly the aptamers detect the target protein by three dimensional 
structure compared to antibodies which detect the amino acids itself.  
 
After being exposed to a certain temperature, the aptamer still could return to the original 
conformation structure but antibodies are well known to be sensitive to temperature and 
undergo irreversible denaturation (Jayasena, 1999). Therefore the shelf-life of the 
aptamers were longer compared to antibodies (Nimjee et. al., 2006). When using 
aptamers as ligands, the immunogenicity reaction that arises is miniscule when compared 
to antibodies where the immunogenicity reaction might be significant. Cross reactive 
compounds can be isolated utilizing a strategy to facilitate preclinical studies unlike 
antibodies where there is no method for isolating cross reactive compound. Aptamer-
specific antidote could be developed to reverse the inhibitory activity of the drug but 
there are no rational method to reverse molecules in antibody reaction (Nimjee et. al., 
2006).  
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Therefore, based on the many advantages described above, aptamers are considered to be 
an alternative to antibodies in many biological applications. In fact aptamers could be a 
rival to commercialised monoclonal and polyclonal antibodies due to the fact that they 
are inexpensive, stable, and can be synthetically manufactured and chemically 
manipulated with relative ease (Joshi et. al., 2009).  
 
1.3. In vitro selection process 
As mentioned earlier, SELEX or in vitro selection is a technique used to isolate aptamers 
with high affinity. Since the 1990’s, in vitro selection was used to identify unique nucleic 
acid-based structure from random sequence of oligonucleotide libraries that could bind 
arbitrarily to the interest target molecules (Ellington and Szostak, 1990, Tuerk and Gold, 
1990) as well as carry out a specific function (Brody and Gold, 2000, Jarosch et. al., 
2006, Keefe and Cload, 2008). It was a process for screening from large libraries of 
oligonucleotides by an iterative process of selection and amplification (Polisky, 1998). 
The basic scheme for in vitro selection is outlined in Figure 1.2.  
 
The SELEX process begins by the generation of a large library of oligonucleotide 
sequences. The sequences are constructed with known flanking sequences at the 5’ and 3’ 
ends and a random region in the middle. The randomized region usually consisted 
between 40 -60 nucleotides. The library also contains between 10
14
 – 1015 different 
DNA/RNA species that fold into numerous sequence-dependent structures (Klussman, 
2006). Then, the sequences from an input library were subjected to a selected target and 
went through a selective procedure. The active molecules that have the capability to bind 
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to the target were separated from the inactive molecules. The sequences that were bound 
to the target were eluted and subsequently amplified by PCR for DNA or reverse 
transcription PCR (RT-PCR) for RNA. Once amplified, the product was transcribed into 
RNA (for RNA aptamer) or the DNA was subjected to the target again. This repeating 
process usually was cycled between 7 – 15 rounds until functional molecules with higher 
affinity for the target protein dominated the population (Dausse et al., 2005). The pool is 
then cloned and sequenced for further analysis (Klussmann, 2006, Proske et al., 2005). 
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Figure 1.2 : General schemes of SELEX process starting with library pool of oligonucleotides, then the selection process and 
separation between the bound and unbound molecules. Subsequently, the bound molecules were subjected to amplification 
process and the whole processes were repeated for several cycles, resulting in the functional molecules, aptamer. (adapted 
from Klussman, 2006)  
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1.4. Applications of aptamer 
Since its discovery in early 1990s (Ellington and Szostak, 1990, Tuerk and Gold, 
1990), aptamer technology has progressed intensively (Proske et. al., 2005). Its 
attributes, as previously mentioned, make aptamers to be very competitive with 
protein affinity reagents. Aptamers are successfully used in different areas of 
biotechnology such as therapeutics, purification processes, target validation, drug 
discovery, diagnostics and therapy. It also has been applied to various targets 
including proteins, whole cells and tissues (Table 1.5 and 1.6) (Hamula et. al., 2011a). 
Their high degree of target specificity and sensitivity are well documented (Joshi et. 
al., 2009). Aptamers have also been used in analytical methodologies such as 
chromatography and biosensor (aptasensor). These aptamer-based methods have been 
mainly employed in the clinical setting for the development of diagnostic assays 
(WHO, 2013).  
 
Most of the applications of the aptamerS are in the therapeutics fields. A viable 
aptamer-based drug, macugen or pegaptanib sodium has been clinically developed to 
help patient manage the devastating disease of age-related macular degeneration 
(AMD). The use of the drug has recently received the approval by the US Food and 
Drug Administration (FDA). There also numerous aptamers that are in preclinical 
development and few of them are scheduled to begin clinical evaluation soon 
(Klussmann, 2006). For example; a novel sandwich ELISA based on an anti-MPT64 
antibody aptamer had been developed by Zhu et. al., (2012). Clinical validation 
showed that the ELISA method was a reliable test for the serological diagnostic of 
pulmonary tuberculosis. Thus the method could be used for diagnostic of the 
tuberculosis (Zhu et. al., 2012).  
